Sugi Predict

Sugi Predict / Compounds / SCHEMBL4650865

SCHEMBL4650865

SCHEMBL4650865

COC(=O)C(C)(C)CCCCBr

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 1/20 0.43
▸ CYP4A11 Q02928 1/20 0.43
▸ TSHR P16473 3/20 0.34
▸ DGAT1 O75907 1/20 0.34
▸ ACLY P53396 1/20 0.34
▸ ACACB O00763 1/20 0.33
▸ ACACA Q13085 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ ACAT1 P24752 1/20 0.32
▸ SOAT1 P35610 1/20 0.32
▸ ELANE P08246 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ HTT P42858 1/20 0.31
▸ FFAR1 O14842 1/20 0.30
▸ CPT2 P23786 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8986987 0.98 CYP4F2 (0.46) CYP4F2CYP4A11TSHRDGAT1ACLY
SCHEMBL9129151 0.98 CYP4F2 (0.46) CYP4F2CYP4A11TSHRDGAT1ACLY
SCHEMBL8987098 0.98 CYP4F2 (0.46) CYP4F2CYP4A11TSHRDGAT1ACLY
SCHEMBL4122676 0.94 CYP4F2 (0.40) CYP4F2CYP4A11TSHRDGAT1ACLY
SCHEMBL1661232 0.85 DGAT1 (0.38) CYP4F2CYP4A11TSHRDGAT1ELANE
SCHEMBL9521999 0.83 CYP4F2 (0.49) CYP4F2CYP4A11KDM4EMAPTTHRB
SCHEMBL28887136 0.82 TSHR (0.54) CYP4F2CYP4A11TSHRKDM4E
SCHEMBL1721309 0.82 CYP4F2 (0.42) CYP4F2CYP4A11DGAT1ACLYACACB
SCHEMBL1996919 0.81 CYP4F2 (0.48) CYP4F2CYP4A11TSHRKDM4ETP53
SCHEMBL6371095 0.81 CYP4A11 (0.63) CYP4F2CYP4A11TSHRDGAT1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0485822-B1 Process for preparing high molecular weight polyolefines HOECHST AG (DE) 1996-07-03 — — EP claimed
US-12617752-B2 Rapidly metabolized lipid compound BEIJING JITAI LIFE SCIENCES LTD (CN) 2026-05-05 — — US disclosed
EP-4729507-A1 RAPIDLY-METABOLIZED LIPID COMPOUND Beijing Jitai Life Sciences Ltd (CN) 2026-04-22 — — EP disclosed
US-20250161482-A1 RAPIDLY METABOLIZED LIPID COMPOUND Beijing Jitai Pharmaceutical Technology Co., Ltd. (CN) 2025-05-22 — — US disclosed
US-20250026713-A1 RAPIDLY METABOLIZED LIPID COMPOUND Beijing Jitai Pharmaceutical Technology Co., Ltd. (CN) 2025-01-23 — — US disclosed
WO-2024255415-A1 RAPIDLY-METABOLIZED LIPID COMPOUND 北京剂泰医药科技有限公司 2024-12-19 — — WO disclosed
CN-119143620-A Quick metabolism lipid compounds of (2) 北京剂泰医药科技有限公司 2024-12-17 — — CN disclosed
WO-2024049979-A2 NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME SENDA BIOSCIENCES, INC. (US) 2024-03-07 — — WO disclosed
CN-117164461-A (4Z, 6E) -4, 6-undecadienyl trimethyl acetate and method for preparing (5Z, 7E) -5, 7-dodecadiene compound from same 信越化学工业株式会社 2023-12-05 — — CN disclosed
CN-111170855-A Compound and method for synthesizing 8-hydroxy-2, 2,14, 14-tetramethylpentadecanedioic acid by using same 奥锐特药业(天津)有限公司 2020-05-19 — — CN disclosed
US-4104474-A PROSTAGLANDINS, HYPOTENSIVE, OXYTOCICS, ANTIFERTILITY, ANTISECRETORY THE UPJOHN COMPANY (US) 1978-08-01 — — US disclosed
US-4099014-A BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1978-07-04 — — US disclosed
US-4099015-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-07-04 — — US disclosed
US-4086258-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-04-25 — — US disclosed
US-4058564-A PROSTAGLANDINS; HYPOTENSIVE, LABOR INDUCERS, ANTISECRETORY THE UPJOHN COMPANY (US) 1977-11-15 — — US disclosed
US-4033989-A 9-Deoxy-PGF2 Analogs THE UPJOHN COMPANY (US) 1977-07-05 — — US disclosed
US-4029681-A 13,14-Didehydro-PG analogs THE UPJOHN COMPANY (US) 1977-06-14 — — US disclosed
US-4026909-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1977-05-31 — — US disclosed
US-4018803-A 13,14-Didehydro-PG3 compounds THE UPJOHN COMPANY (US) 1977-04-19 — — US disclosed
US-4016184-A PROSTAGLANDINS, BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1977-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026713-A1 RAPIDLY METABOLIZED LIPID COMPOUND SLC10A1, NPC1, POLRMT CYP4F2 113/4885CYP4A11 39/4885TSHR 2531/4885
US-12617752-B2 Rapidly metabolized lipid compound LDLR, SLC10A1, LRAT CYP4F2 405/4885CYP4A11 45/4885TSHR 666/4885
US-20250161482-A1 RAPIDLY METABOLIZED LIPID COMPOUND NPC1, SLC10A1, POLRMT CYP4F2 173/4885CYP4A11 51/4885TSHR 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.